Low Grade Ovarian Serous Adenocarcinoma
5 clinical trials · Condition
◉ Watch Low Grade Ovarian Serous Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| A Study of Avutometinib (VS-6766) v. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer With and Without a KRAS Mutation (NCT04625270) | Verastem, Inc. | 2020-12-21 |
| Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer (NCT00551070) | National Cancer Institute (NCI) | 2007-12-17 |
| Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors (NCT00488878) | M.D. Anderson Cancer Center | 2006-05-19 |
Track Low Grade Ovarian Serous Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.